Love, R. “By the Metrics Surgical Oophorectomy Plus Tamoxifen Is the First Adjuvant Treatment Option for Premenopausal Women With Hormone Receptor Positive Breast Cancer”. Archives of Breast Cancer, Jan. 2021, pp. 8-13, doi:10.32768/abc.2021818-13.